{"organizations": [], "uuid": "a50672b103268e268b9b7f2f0a47851a265acb1c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cytrx-corp-announces-its-entry-int/brief-cytrx-corp-announces-its-entry-into-a-definitive-agreement-with-destum-partners-idUSFWN1QI14O", "country": "US", "domain_rank": 408, "title": "BRIEF-Cytrx Corp Announces Its Entry Into A Definitive Agreement With Destum Partners", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.848, "site_type": "news", "published": "2018-02-28T22:27:00.000+02:00", "replies_count": 0, "uuid": "a50672b103268e268b9b7f2f0a47851a265acb1c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cytrx-corp-announces-its-entry-int/brief-cytrx-corp-announces-its-entry-into-a-definitive-agreement-with-destum-partners-idUSFWN1QI14O", "ord_in_thread": 0, "title": "BRIEF-Cytrx Corp Announces Its Entry Into A Definitive Agreement With Destum Partners", "locations": [], "entities": {"persons": [{"name": "destum", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cytrx corp", "sentiment": "negative"}, {"name": "brief-cytrx corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "cytrx", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Cytrx Corp:\n* CYTRX CORP - ANNOUNCED ITS ENTRY INTO A DEFINITIVE AGREEMENT WITH DESTUM PARTNERS\n* CYTRX - ‍ DESTUM WILL BE EXCLUSIVE ADVISOR FOR IDENTIFICATION OF PARTNERSHIP OPPORTUNITIES FOR CO‘S LADR ULTRA-HIGH POTENCY DRUG CONJUGATES​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T22:27:00.000+02:00", "crawled": "2018-03-01T21:04:39.011+02:00", "highlightTitle": ""}